Leo Pharma As

Denmark · Reporting entity ID 100000005663

Total reported 2019–2025

$30.5M

#236 of 2,960 reporting companies — 0% of all reported industry payments

$2.15M in general payments across 1,567 records, plus $28.3M in research funding across 4,124 records.

How it breaks down

General payments $2,153,876

Research funding $28,339,886

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.